Nasdaq

Masimo Announces FDA Clearance of Radius PCG™ for the Root® Patient Monitoring and Connectivity Platform

IRVINE, Calif.--(BUSINESS WIRE)-- Masimo (NASDAQ: MASI) announced today that Radius PCG™, a portable real-time capnograph with wireless Bluetooth® connectivity, has received FDA 510(k) clearance.
FierceBiotech

Masimo wireless, wearable patient monitor cleared by FDA

Masimo ($MASI) has gained FDA clearance for its wireless, wearable patient monitor, Radius-7. The device connects to Root, Masimo's open architecture, patient ...
Business Wire

Masimo Announces Development of Delta cHb, HHb, and O 2 Hb Indices for O3

In 2013, Masimo introduced the Root ® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and ...
Business Wire

Masimo Announces FDA Clearance and Worldwide Release of NomoLine™ Capnography Sampling Lines

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ:MASI) announced today FDA clearance and U.S. release of the full family of NomoLine™ capnography sampling lines. NomoLine sampling lines are available ...
Mena FN

Masimo and Philips licensing agreement brings Masimo NomoLine Capnography and O3 Regional Oximetry to select Philips patient monitors Amsterdam Stock Exchange:NL0000009538

Amsterdam, the Netherlands and Irvine California – Masimo (NASDAQ: MASI) and Royal Philips (NYSE: PHG; AEX: PHIA), both global leaders in patient monitoring, announced today that they have reinforced ...